Form 4 for NVCR NovoCure Ltd
Accepted 2023-03-06 00:00:00 ET · period of report 2023-03-03 · accession 0001562180-23-002494 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-06 | 2023-03-03 | NVCR | Weinberg Uri | Chief Innovation Off | A - Grant | $0.00 | +32.8K | 89.0K | +58% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-03-03 | A | A | 28,830 | $0.00 | 85,108 | D | — | — | (F1) Represents vesting of performance-based restricted stock units. |
| 2 | Common | Ordinary Shares | 2023-03-03 | A | A | 3,936 | $0.00 | 89,044 | D | — | — | (F1) Represents vesting of performance-based restricted stock units. |